Ending the pandemic could depend on following the evidence about what it takes to support and encourage preventive health care.

People of color and those with lower incomes or education less likely to say they’ll seek vaccination.

A U-M study found that type 1 diabetes rates were one-third lower in children who received all doses of the rotavirus vaccine.

U-M researchers aim to develop a new immunotherapy that could alter the immune reactions to food. The result: extended relief from peanut allergies.

An economic analysis led by a U-M expert found reason to recommend Shingrix to everyone over age 50. As the vaccine hits the market, its merits will be continually evaluated.